Dysproteinemias


A set of diseases known as dysproteinemias are defined by an excessive synthesis of a monoclonal (M) protein as a result of aberrant clonal growth of plasma cells. An immunoglobulin fragment (light chain or heavy chain) or a whole immunoglobulin can both be this M protein. These conditions are collectively referred to as "dysproteinemias," "paraproteinemias," or "monoclonal gammopathies" and include multiple myeloma, light-chain amyloidosis, monoclonal gammopathy of uncertain significance, and others.


    Related Conference of Dysproteinemias

    April 16-17, 2025

    13th European Congress on Nephrology, Internal Medicine and Kidney Diseases

    Paris, France
    May 05-06, 2025

    7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development

    Rome, Italy
    May 26-27, 2025

    29th European Nephrology Conference

    Rome, Italy
    June 23-24, 2025

    26th Global Nephrology, Urology and Kidney Failure Congress

    Paris, France
    June 23-24, 2025

    14th International Conference on Nephrology & Therapeutics

    Aix-en-Provence, France
    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    March 26-27, 2026

    6th International Conference on Kidney Failure & Renal Care

    London, UK
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands

    Dysproteinemias Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in